
Equillium rose 53.7% from $0.92 to $1.42, ahead of the S&P 500's +10.8%. Its worst day was Jan 6 (−17.8%), and its low came Nov 13 at $0.84.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.06 beat the $-0.19 estimate on $0.00 revenue.
+23.8% · S&P 500 0.0%
Equillium shares rose 25.2%, while the S&P 500 rose 0.2%.
Story events cover the past 12 months · Times ET
+25.2%, the year's best day · S&P 500 +0.2%
Equillium shares rose 21.7%, while the S&P 500 rose 0.6%.
+21.7% · S&P 500 +0.6%
Equillium shares fell 17.8%, while the S&P 500 rose 0.6%.
−17.8%, the year's worst day · S&P 500 +0.6%
Equillium shares rose 19.3%, while the S&P 500 fell 0.6%.
+19.3% · S&P 500 −0.6%
EPS of $-0.04 beat the $-0.07 estimate on $0.00 revenue.
0.0% · S&P 500 −1.8%
EPS of $-0.06 missed the $-0.04 estimate on $0.00 revenue.
+12.1% · S&P 500 +0.8%
Equillium closed at its highest level of the year, 246.3% above where the year started.
+3.9% · S&P 500 +0.8%
EPS of $-0.04 beat the $-0.06 estimate on $0.00 revenue.
+17.4% · S&P 500 −0.2%
Where it ended: a close of $1.42 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.05).
Nothing in the past 12 months.
All EQ dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EQ and SPY from Benzinga historical bars. Not investment advice.